← Leaderboards
Louis S Premkumar
Southern Illinois University Carbondale
$3,194,994
Attributed
$3,194,994
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $298.7K · FY2005–19$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$3,194,994 · 5
By mechanism
R01$2,906,403 · 3
R43$215,841 · 1
R56$72,750 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Receptor”
- Barton F Haynes · Duke University$182,835,224
- James C. Paulson · Scripps Research Institute$84,068,192
- Asrar B. Malik · University Of Illinois At Chicago$55,280,031
- Anthony O Caggiano · Cognition Therapeutics, Inc.$49,563,751
- Robert J Coffey · Vanderbilt University$48,115,270
- Robert H Vonderheide · University Of Pennsylvania$48,030,034
Research focus
ReceptorPainCapsaicinLaboratory MouseMembrane ChannelsAgonistAreaRattusSkinResiniferatoxinPreparationNervePeripheralEsthesiaPreventVanilloidDiabeticPhosphorylationProtein Kinase CMechanicsMediatingInflammatoryAfferent NeuronsEffectiveness
Grant awards (15)
Development and evaluation of a polymer coated proprietary cream formulation of resiniferatoxin nanoparticles for the treatment of pain associated with Diabetic Peripheral Neuropathy$215,841
R43 · FY2019 · DK · contact PI
A Novel Approach for Chronic Pain Treatment Using Resiniferatoxin$254,856
R01 · FY2013 · DA · contact PI
A Novel Approach for Chronic Pain Treatment Using Resiniferatoxin$265,475
R01 · FY2012 · DA · contact PI
A Novel Approach for Chronic Pain Treatment Using Resiniferatoxin$265,475
R01 · FY2011 · DA · contact PI
A Novel Approach for Chronic Pain Treatment Using Resiniferatoxin$273,686
R01 · FY2010 · DA · contact PI
A Novel Approach for Chronic Pain Treatment Using Resiniferatoxin$298,710
R01 · FY2009 · DA · contact PI
Role of Vanilloid Receptors in Diabetic Peripheral Neuropathy$72,750
R56 · FY2008 · DK · contact PI
Vanilloid Receptors in Diabetic Peripheral Neuropathy$251,351
R01 · FY2006 · DK · contact PI
Vanilloid Receptors in Diabetic Peripheral Neuropathy$257,400
R01 · FY2005 · DK
Vanilloid Receptors in Diabetic Peripheral Neuropathy$257,400
R01 · FY2004 · DK
Endogenous Activators of Vanilloid Receptor$176,250
R01 · FY2004 · NS
Endogenous Activators of Vanilloid Receptor$176,250
R01 · FY2003 · NS
Endogenous Activators of Vanilloid Receptor$50,000
R01 · FY2003 · NS
Endogenous Activators of Vanilloid Receptor$176,250
R01 · FY2002 · NS
Endogenous Activators of Vanilloid Receptor$203,300
R01 · FY2001 · NS